You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Adjuvants, Immunologic

Showing 1 - 25 of 940
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Recurrent Glioblastoma Trial in Portland (TVI-Brain 1)

Available
  • Recurrent Glioblastoma
  • TVI-Brain 1
  • Portland, Oregon
    Providence St. Vincent Medical Center
Jun 28, 2023

HIV Trial in Saint Louis, Rochester, Seattle (Aluminum hydroxide, Lipid A, Monophosphoryl, Lipid A, Liposome-encapsulated

Completed
  • HIV Infections
  • Aluminum hydroxide
  • +7 more
  • Saint Louis, Missouri
  • +2 more
Oct 28, 2021

Immunomodulators Associated With Atrial Fibrillation Reporting:

Completed
  • Atrial Fibrillation
  • Immunomodulators with FDA approval on the 1st January 2023.
  • Caen, Basse Normandie, France
    Alexandre Joachim
Oct 17, 2023

HIV, HIV Seronegativity Trial in Rochester, Nashville, Seattle (Env 2-3)

Completed
  • HIV Infections
  • HIV Seronegativity
  • Env 2-3
  • Rochester, New York
  • +2 more
Oct 26, 2021

HIV, HIV Seronegativity Trial in Rochester, Nashville, Seattle (MTP-PE/MF59, Env 2-3)

Completed
  • HIV Infections
  • HIV Seronegativity
  • MTP-PE/MF59
  • Env 2-3
  • Rochester, New York
  • +2 more
Oct 28, 2021

HIV Trial in United States (MN rgp120/HIV-1 and A244 rgp120/HIV-1, QS-21, rgp120/HIV-1MN)

Completed
  • HIV Infections
  • MN rgp120/HIV-1 and A244 rgp120/HIV-1
  • +2 more
  • Baltimore, Maryland
  • +3 more
Oct 28, 2021

HIV Trial in United States (MF59, rgp120/HIV-1 SF-2)

Completed
  • HIV Infections
  • MF59
  • rgp120/HIV-1 SF-2
  • Birmingham, Alabama
  • +3 more
Oct 27, 2021

HIV Trial in New York (AS-101)

Completed
  • HIV Infections
  • New York, New York
    Mount Sinai Med Ctr
Oct 28, 2021

HIV Trial in Rochester (MTP-PE/MF59, Env 2-3)

Completed
  • HIV Infections
  • MTP-PE/MF59
  • Env 2-3
  • Rochester, New York
    Univ. of Rochester AVEG
Oct 27, 2021

HIV Trial (gp160 MN/LAI-2, Aluminum hydroxide)

Completed
  • HIV Infections
  • gp160 MN/LAI-2
  • Aluminum hydroxide
  • (no location specified)
Oct 13, 2021

HIV Trial in United States (Interferon alfa-n3, Interferon alfa-n1)

Completed
  • HIV Infections
  • Interferon alfa-n3
  • Interferon alfa-n1
  • Los Angeles, California
  • +14 more
Oct 27, 2021

HIV Trial in United States (Aluminum hydroxide, QS-21, rgp120/HIV-1MN)

Completed
  • HIV Infections
  • Aluminum hydroxide
  • +2 more
  • Saint Louis, Missouri
  • +4 more
Oct 28, 2021

HIV Trial in United States (Aluminum hydroxide, MF59, rgp120/HIV-1IIIB)

Completed
  • HIV Infections
  • Aluminum hydroxide
  • +5 more
  • Los Angeles, California
  • +9 more
Oct 27, 2021

HIV Trial in United States (Aluminum hydroxide, QS-21, rgp120/HIV-1MN)

Completed
  • HIV Infections
  • Aluminum hydroxide
  • +2 more
  • Saint Louis, Missouri
  • +3 more
Oct 28, 2021

Diffuse Intrinsic Pontine Glioma (DIPG), Brain Stem Glioma Trial in Gainesville (TTRNA-DC vaccines with GM-CSF, TTRNA-xALT,

Recruiting
  • Diffuse Intrinsic Pontine Glioma (DIPG)
  • Brain Stem Glioma
  • TTRNA-DC vaccines with GM-CSF
  • +5 more
  • Gainesville, Florida
    UF Health Shands Children's Hospital
Apr 29, 2022

HIV Trial in United States (VRC-HIVDNA009-00-VP (Gag-Pol-Nef-multiclade-Env) with adjuvant VRC-ADJDNA004-IL2-VP)

Completed
  • HIV Infections
  • VRC-HIVDNA009-00-VP (Gag-Pol-Nef-multiclade-Env) with adjuvant VRC-ADJDNA004-IL2-VP
  • Baltimore, Maryland
  • +6 more
Oct 13, 2021

Novel Mechanisms and Approaches to Treat Neonatal Sepsis

Recruiting
  • Complication of Prematurity
  • Immunologic Deficiency Syndromes
  • Adjuvant
  • Blood Collection
  • Gainesville, Florida
    UF Health
Nov 4, 2021

Postoperative Pain Management, Postoperative Pain, Analgesia Trial in I?stanbul (Quadratus Lumborum Block III, Quadratus

Recruiting
  • Postoperative Pain Management
  • +5 more
  • Quadratus Lumborum Block III
  • Quadratus lumborum block III with Adjuvant
  • İ̇stanbul, Marmara, Turkey
    Gaziosmanpasa Research and Education Hospital
Aug 31, 2023

Cytomegalovirus Infections Trial in Manchester (SPYVAC01)

Not yet recruiting
  • Cytomegalovirus Infections
  • SPYVAC01
  • Manchester, United Kingdom
    Medicines Evaluation Unit
Nov 20, 2023

Bupivacaine, Dexamethasone, Magnesium Sulphate Trial in VAN (Bupivacaine + dexamethasone, Bupivacaine + magnesium sulphate,

Completed
  • Bupivacaine
  • +3 more
  • Bupivacaine + dexamethasone
  • +2 more
  • VAN, Turkey
    Haci Yusuf GUNES
Oct 16, 2023

Refractory Leukemia, Relapsed Leukemia, Acute Myelogenous Leukemia Trial in Miami (STING-Dependent Activators (STAVs) Loaded

Not yet recruiting
  • Refractory Leukemia
  • +4 more
  • STING-Dependent Activators (STAVs) Loaded Autologous Leukemic Cells
  • Dendritic Cell Vaccine
  • Miami, Florida
    University of Miami
Jan 23, 2023

Pain, Postoperative, Pain, Acute, Pain, Chronic Trial in Athens (erector spinae plane block with a combination of ropivacaine

Not yet recruiting
  • Pain, Postoperative
  • +5 more
  • erector spinae plane block with a combination of ropivacaine and morphine
  • +2 more
  • Athens, Greece
  • +1 more
May 3, 2023

Postoperative Pain Trial (Dexmedetomidine, Midazolam, Bupivacain)

Not yet recruiting
  • Postoperative Pain
  • (no location specified)
Oct 13, 2023

Altered Transcriptomic and Immune Accompanied by Identification

Recruiting
  • Breast Cancer Patients
  • surgery for breast cancer and imaging test evaluations
  • Naples, Italy
    IRCCS Synlab SDN
Mar 29, 2023

HIV Trial in Boston (CH505 TF chTrimer, 3M-05-AF, Aluminum hydroxide suspension)

Active, not recruiting
  • HIV Infections
  • CH505 TF chTrimer
  • +2 more
  • Boston, Massachusetts
    Brigham and Women's CRS
Jan 31, 2022